Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors

PURPOSE: Subsets of pituitary tumors exhibit an aggressive clinical courses and recur despite surgery, radiation, and chemotherapy. Because modulation of the immune response through inhibition of T-cell checkpoints has led to durable clinical responses in multiple malignancies, we explored whether p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Mei, Yu, Bi, Wenya Linda, Greenwald, Noah F., Du, Ziming, Agar, Nathalie Y. R., Kaiser, Ursula B., Woodmansee, Whitney W., Reardon, David A., Freeman, Gordon J., Fecci, Peter E., Laws, Edward R., Santagata, Sandro, Dunn, Gavin P., Dunn, Ian F.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5363530/
https://ncbi.nlm.nih.gov/pubmed/27655724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12088
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados